Clinical Trials Logo

Soft Tissue Injuries clinical trials

View clinical trials related to Soft Tissue Injuries.

Filter by:

NCT ID: NCT02145130 Completed - Scars Clinical Trials

Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects

Start date: May 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is the evaluation of the safety of autologous tissue-engineered dermal substitutes "denovoDerm" (first arm) and dermo-epidermal skin substitutes "denovoSkin" (second arm) transplanted onto the wound bed in children and adults.

NCT ID: NCT02132247 Completed - Athletic Injuries Clinical Trials

Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries

Start date: May 2014
Phase: Phase 4
Study type: Interventional

The primary purpose of this study is to determine whether Flector Patch is safe for use in children. The secondary purpose is to assess blood levels of diclofenac, the active ingredient in Flector Patch.

NCT ID: NCT01927003 Completed - Clinical trials for Soft Tissue Injuries

Direct and Reversed Dorsal Digito-metacarpal Flaps: A Review of 24 Cases

Start date: April 2009
Phase: N/A
Study type: Interventional

Multiple digital injuries are often complex and severe, and the commonly used local and regional flaps may not be feasible. The authors reconstruct soft tissue defects of the fingers using the dorsal digito-metacarpal flap and evaluate the efficacy of this technique.

NCT ID: NCT01767727 Completed - Clinical trials for Soft Tissue Injuries

Repair of Multiple Finger Defects Using the Dorsal Homodigital Island Flaps

Start date: March 2008
Phase: N/A
Study type: Interventional

Multiple finger defects are common in hand trauma and result in functional disability. These injuries are often complex and severe, and thus reconstructive alternatives are limited. In this study, we use the dorsal homodigital island flaps, based on the dorsal branch of the digital artery, for reconstruction of multiple finger defects. At the final follow-up, we would evaluate the efficacy of this technique.

NCT ID: NCT01759498 Completed - Clinical trials for Soft Tissue Injuries

The Effects of Hydrogen-rich Formulation for Treatment of Sport-related Soft Tissue Injuries

Start date: December 2012
Phase: Phase 2
Study type: Interventional

Since hydrogen therapy in humans seems to be beneficial for treating inflammation, ischemia-reperfusion injury and oxidative stress, it seems plausible to evaluate the effects of exogenously administered hydrogen as an element of instant management of sport-related soft tissue injuries (e.g. muscle sprain, ligament strain, tendonitis, contusion). The main aim of the present study will be to examine the effects of two-week hydrogen-rich oral and topical administration on the inflammation, recovery and functional abilities in competitive male and female athletes after acute soft-tissue injury. During the season 2012/2013 (from February to June) subjects (36 professional athletes) will be recruited and examined by certified sports medicine specialist in the out-patient clinics of the Center for Health, Exercise and Sport Sciences in the first 24 hours after the sport-related soft tissue injury was sustained. The subjects will be allocated to a double-blind design to three randomly assigned trials. During the period of 2 weeks subjects in the placebo group (PLA) will receive traditional treatment protocol after the soft-tissue injury, consisting of RICE protocol during the first 48 h and sub-acute protocol thereafter. Subjects in the first experimental group will follow the above procedures with additional administration of oral hydrogen-rich capsules (4 capsules three times per day) throughout the study. Subjects in the second experimental group will follow the procedures of first experimental group with additional administration of hydrogen-rick packs 6 times per day for 20 minutes throughout the study. Participants will be evaluated at the beginning of the study (e.g. at the time of the injury report), after 7 and 14 days after baseline testing for: a) serum C-reactive protein, plasma viscosity and interleukin 6 level, b) pain intensity during rest and walking, c) degree of joint swelling, d) passive joint flexibility, and, e) subjective side-effects. The investigators expect that the administration of hydrogen will significantly improve inflammation outcomes (e.g. decrease in serum C-reactive protein) as compared to the placebo, with topical hydrogen administration will additionally improve post-injury recovery outcomes (e.g. pain intensity, degree of swelling). These results could support the hypothesis that hydrogen-rich intervention may be included as an element of immediate treatment for sport-related soft tissue injuries.

NCT ID: NCT01626235 Completed - Dysmenorrhea Clinical Trials

AMPED Outcomes Registry of Post-ED Pain Management

AMPED
Start date: July 2012
Phase: N/A
Study type: Observational

Study aims to assess patient-recorded outcomes of pain control medications prescribed in the ER after visits for specific painful injuries/illnesses.

NCT ID: NCT01292876 Completed - Muscle Injury Clinical Trials

Musculotendinous Tissue Repair Unit and Reinforcement (MTURR)

MTURR
Start date: December 2010
Phase: N/A
Study type: Interventional

The objective of the study is to assess mechanical strength and function in subjects undergoing Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) with the use of biologic scaffolds for the restoration of both mechanical strength and function in these subjects. This study formally evaluated healing and return of function after an extracellular matrix device implantation in 17 male and female subjects participating at the University of Pittsburgh under the Department of Plastic and Reconstructive Surgery who suffer from injury with loss of skeletal muscle tissue.

NCT ID: NCT01272947 Completed - Clinical trials for Acute Blunt Soft Tissue Injuries/Contusions

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries

Start date: January 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of DSG 1% compared with placebo applied four times a day in subjects with acute blunt soft tissue injuries/contusions of the limbs

NCT ID: NCT00931866 Completed - Acute Pain Clinical Trials

Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED)

Start date: April 2009
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium topical patch in reducing mild to moderate soft tissue injuries when applied to the painful area.

NCT ID: NCT00796094 Completed - Soft Tissue Injury Clinical Trials

Imaging of Soft Tissues

Start date: December 2008
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the potential importance of tissue elasticity in the assessment of soft tissues including muscles, tendons and ligaments and other soft tissue structures. The evaluation of tissue elasticity (easily stretched or moveable) may assist in assessment of various soft tissue structures, such as fatty atrophy of muscles, tendon/ligamentous injury and healing and other soft tissue structures.